References
- Rosenstein N, Phillips WR, Gerber MA, et al. The common cold—principles of judicious use of antimicrobial agents. Pediatrics (Suppl) 1998; 101: 181–4
- O'Brien KL, Dowell SF, Schwartz B, et al. Acute sinusitis—principles of judicious use of antimicrobial agents. Pediatrics (Suppl) 1998; 101: 174–7
- Dowell SF, Marcy SM, Phillips WR, et al. Otitis media—principles of judicious use of antimicrobial agents. Pediatrics (Suppl) 1998; 101: 165–71
- O'Brien KL, Dowell SF, Schwartz B, et al. Cough illness/bronchitis—principles of judicious use of antimicrobial agents. Pediatrics (Suppl) 1998; 101: 178–81.
- Rosenfeld RM, Vertrees JE, Carr J, et al. Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials. J Pediatr 1994: 124(3): 355–67
- Blumer JL. Pharmacokinetics and pharmacodynamics of new and old antimicrobial agents for acute otitis media. Pediatr Infect Dis J 1998; 17(11): 1070–5
- Goldstein NA, Casselbrant ML, Bluestone CD, et al. Intratemporal complications of acute otitis media in infants and children. Otolaryngol Head Neck Surg 1998; 119(5): 444–54
- Block SL. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. Pediatr Infect Dis J 1997; 16(4): 449–56
- Ahuja GS, Thompson J. What role for antibiotics in otitis media and sinusitis? Postgrad Med 1998; 104(3): 93–104
- Weiss LR. Developing cost-effective guidelines for the appropriate use of antimicrobial therapy in respiratory tract infection. Am J Man Care 1998; 4(Suppl 10): 572–90S
- Heiskanen-Kosma T, Korppi M, Jokinen C, et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J 1998; 17(11): 986–91
- Harrison CJ. Rational selection of antimicrobials for pediatric upper respiratory infections. Pediatr Infect Dis J 1995; 14(7): S121–9
- Thornsberry C, Ogilvie P, Kahn J, et al, for the Laboratory Investigator Group. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory season. Diagn Microbiol Infect Dis 1997; 29(4): 249–57
- Doern GV, Jones RN, Pfaller MA, et al, and the SENTRY Participants Group. Haemophilus influenzae and Moraxella catarrhalis from patients with community acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob Agents Chemother 1999; 43(2): 385–9
- Doern GV, Brueggemann A, Holley HP, et al. Antimicrobial therapy of Streptococcus pneumoniae recovered from outpatients in the US during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996; 40(5): 1208–13
- Doern GV, Pfaller MA, Kugler K, et al. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis 1998; 27(4): 764–70
- Klein JO. Clinical implications of antibiotic resistance for management of acute otitis media. Pediatr Infect Dis J 1998; 17(11): 1084–9
- Singh J, Arrieta AC. New cephalosporins. Semin Pediatr Infect Dis 1999; 10(1): 14–22
- Harrison CJ. Perspectives on newer oral antimicrobials: what do they add? Pediatr Infect Dis J 1995; 14(5): 436–44
- Steele RW, Estrada B, Begue RE, et al. A double-blind taste comparison of pediatric antibiotic suspensions. Clin Pediatr 1997;36(4):193–9
- Bluestone CD. Summary and conclusions of the meeting. Pediatr Infect Dis J 1998; 17(11): 1099–103
- Doern GV. Mechanisms and current rates of resistance. Am J Man Care 1998; 4(Suppl 10): 531–7S
- Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media. Pediatr Infect Dis J 1998; 17(12); 1126–31
- Benninger MS, Anon J, Mabry RL. The medical management of rhinosinusitis. Otolaryngol Head Neck Surg 1997; 117 (3 Pt 2): 41–9S
- Weiss LR. Therapeutic pathways for antimicrobial use: general overview. Am J Man Care 1998; 4(Suppl 10): 543–9S
- Drlica K. Refining the fluoroquinolones. ASM News 1999; 65(6): 410–5